Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study

Autor: Kevin L. Winthrop, Kenneth Saag, Matthew D. Cascino, Jinglan Pei, Ani John, Angelika Jahreis, Tmirah Haselkorn, Daniel E. Furst, M. Abdulky, M. Abeles, H. Adelglass, A. Ahmed, J. Alloway, J. Alper, A. Anand, J. Anderson, M. Arora, A. Askari, S. Baca, D. Bacha, S. Bagheri, S. Ballou, R. Bennett, L. Bidula, H. Blumstein, M. Bognar, A. Bohan, C. Boniske, M. Borofsky, E. Box, A. Braun, T. Brennan, L. Brent, I. Cabalar, N. Carteron, K. Chaudhary, A. Chauhan, M. Cima, A. Cochinwala, H. Cohen, K. Colburn, D. Conaway, C. Danning, K. Dao, J. Dean, I. Diab, R. Diegel, R. Ditzian‐Kadanoff, J. Dowd, C. Dugowson, A. Eggebeen, H. El‐Kadi, H. Feinberg, M. Feinman, J. Feinstein, A. Fischer, B. Foad, M. Fondal, S. Fraser, A. Fraser, P. Freeman, M. Garber, A. Goldstein, S. Golombek, N. Greenstein, M. Greenwald, C. Hakim, J. Halla, D. Hallegua, K. Han, B. Harris, H. Hauptman, J. Hirsh, M. Hoffman, J. Huntwork, M. Husni, F. Hyer, R. Hymowitz, R. Jones, S. Kanagasegar, J. Kappes, R. Keating, G. Kelly, J. Kim, C. King, D. Klashman, C. Knee, K. Kolba, G. Krick, H. Krug, U. Kumar, S. Lakhanpal, T. Lang, S. Lauter, T. Lawrence Ford, W. Lee, Y. Lee, J. Leisen, J. Levine, R. Lidman, J. Lipstate, J. Malinak, R. Marcus, D. Martin, C. Mehta, G. Melton, S. Metyas, K. Miller, R. Moidel, C. Moore, J. Mossell, G. Munoz, F. Murphy, A. Nami, J. Nascimento, N. Neal, R. Neiman, C. Neuwelt, P. Nguyen, M. Niemer, K. Oelke, M. Oza, S. Pachaidee, S. Patel, S. Pegram, M. Penmetcha, J. Perkins, A. Perl, L. Peterson, R. Pittsley, K. Portnoff, D. Rahmani, N. Raja, W. Ratnoff, M. Rezaian, C. Rhea, D. Rice, D. Ridley, A. Rivadeneira, W. Rizzo, G. Roane, P. Rocca, M. Rosen, W. Saikali, M. Saitta, A. Sankoorikal, P. Saway, P. Schneider, S. Schwartzman, C. Scoville, W. Shergy, W Shiel, R. Shurmur, D. Sikes, A. Singhal, A. Snyder, S. Songcharoen, M. Sosenko, O. Soto Raices, N. Stahl, K. Stark, M. Strachan, A. Stupi, N. Sullivan, R. Sylvester, D. Tabechian, C. Tagoe, P. Taylor, S. Thakker, M. Thakor, N. Thakur, W. Tidmore, M. Toth, D. Trostle, J. Udell, M. Van de Stouwe, R. Venuturupalli, D. Weiss, K. Weselman, D. Winn, C. Yung, E. Zable, B. Zamiri

Publikováno v: Arthritis Care & Research

Objective To evaluate the long‐term safety of rituximab in an observational cohort of patients with rheumatoid arthritis (RA) who had an inadequate response to ≥1 anti–tumor necrosis factor therapy in the US (SUNSTONE [Study of the Safety of Ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5502e0d966222c7403f4d23428329950
https://doi.org/10.1002/acr.23781

THU0376 Real-world use of secukinumab with and without a loading regimen among patients with ankylosing spondylitis in the united states: patient profile and dosing

Autor: G Chun, K Oelke, Yue Li, Yujin Park, X Liu

Publikováno v: Poster Presentations.

Background Secukinumab is a fully human anti–interleukin-17 monoclonal antibody approved for the treatment of patients with moderate to severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis (AS), and may be administered with or wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8b66f74b09839db3521dcdfeb826cf1
https://doi.org/10.1136/annrheumdis-2017-eular.1543

FRI0501 Real-world use of secukinumab in patients with psoriatic arthritis in the united states: patient profile and dosing regimen use

Autor: Jacqueline B. Palmer, X Liu, Yue Li, G Chun, K Oelke

Publikováno v: Poster Presentations.

Background As of January 15, 2016, secukinumab became the first fully human anti–interleukin-17 monoclonal antibody approved for the treatment of patients with psoriatic arthritis (PsA) in the United States. Secukinumab may be administered with or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8acac95f04b3197e460f2d41b83e69ca
https://doi.org/10.1136/annrheumdis-2017-eular.1541

Exercise testing raises serum cholesterol

Autor: R F, Hundley, K, Oelke, N, Chesser

Publikováno v: The Journal of the Arkansas Medical Society. 85(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a1375ce74199a622aaf747a9a27ae231
https://pubmed.ncbi.nlm.nih.gov/2525546

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.